An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer
- Type
- Article
- Citation
- NATURE COMMUNICATIONS, v.12, no.1, pp.183
- Issued Date
- 2021-01
- Abstract
- We have reported that autophagy is crucial for clearance of amyloidogenic human IAPP (hIAPP) oligomer, suggesting that an autophagy enhancer could be a therapeutic modality against human diabetes with amyloid accumulation. Here, we show that a recently identified autophagy enhancer (MSL-7) reduces hIAPP oligomer accumulation in human induced pluripotent stem cell-derived beta-cells (hiPSC-beta-cells) and diminishes oligomer-mediated apoptosis of beta-cells. Protective effects of MSL-7 against hIAPP oligomer accumulation and hIAPP oligomer-mediated beta-cell death are significantly reduced in cells with knockout of MiTF/TFE family members such as Tfeb or Tfe3. MSL-7 improves glucose tolerance and beta-cell function of hIAPP(+) mice on high-fat diet, accompanied by reduced hIAPP oligomer/amyloid accumulation and beta-cell apoptosis. Protective effects of MSL-7 against hIAPP oligomer-mediated beta-cell death and the development of diabetes are also significantly reduced by beta-cell-specific knockout of Tfeb. These results suggest that an autophagy enhancer could have therapeutic potential against human diabetes characterized by islet amyloid accumulation.
- Publisher
- NATURE RESEARCH
- ISSN
- 2041-1723
- Appears in Collections:
- Department of Chemistry > 1. Journal Articles
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.